BioCentury
ARTICLE | Clinical News

Nasulin intranasal insulin: Phase I data

November 17, 2008 8:00 AM UTC

In an Irish Phase I trial in 13 healthy male volunteers, the comparative absorption of Nasulin to subcutaneous insulin was 12% in the dominant nostril (more open at time of dosing) and 15% in the non-...